FLT3 and acute myeloid leukemia: Another study regarding FLT3–ITD AML discovered that IL15 plays a role in mediating resistance to FLT3 inhibitors by increasing phosphorylation of ERK in FLT3i-resistant samples, but it can also be used as a biomarker predicting the response to targeted treatment with FLT3i [105].